Search Results - jung-hyun+kim

7 Results Sort By:
Nandrolone 17 Beta-Carbonates
Abstract: The available options for male contraceptives are limited. Androgens are administered as part of hormone-based male contraception and have also been used in the treatment of hypogonadism and hormone replacement therapy HRT. Many synthetic androgens require an oil-based delivery vehicle and have limited durations of action. This technology...
Published: 7/1/2024   |   Inventor(s): Richard Blye, Hyun Kim, Min Lee
Keywords(s): 19-nortestosterone, Androgenic Compounds, Blye, Male Contraceptive, Nandrolone, National Institute of Child Health and Human Development, NICHD
Category(s): TherapeuticArea > Endocrinology, Collaboration Sought > Licensing, Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Reproductive Health
Cell-free RNA biomarkers capable of distinguishing cancer from premalignant disease
Summary Early cancer detection is critical for improving long-term patient survival and highlights a need for new sensitive and minimally-invasive early detection methods. The current technology includes novel sets of cell-free RNA biomarkers that can be used to potentially distinguish between malignant and pre-malignant forms of certain cancers using...
Published: 6/15/2022   |   Inventor(s): Thuy Ngo, Hyun Kim, Josiah Wagner, Breeshey Roskams-Hieter, Pavana Anur
Keywords(s): Diagnostics, Diagnostics - Cancer
Category(s): Diagnostics
Fecal Bacterial Markers for Non-Invasive Diagnosis of Colorectal Cancer
[Licensing negotiation in progress][Invitation for Expression of Interest - Deadline: 19 July 2018]We are inviting expressions of interest (EoI) for commercializing “Fecal Bacterial Markers for Non-invasive Diagnosis of Colorectal Cancer” technology. The innovation is developed by Professor YU Jun, Professor of Department of Medicine &...
Published: 6/20/2023   |   Inventor(s): Jun Yu, Jao Yiu Joseph Sung, Qiaoyi Liang
Keywords(s):  
Category(s): Diagnostics
Diagnosis of intellectual disability and developmental delay
OPPORTUNITY The overall understanding of the molecular etiologies of intellectual disability (ID) and developmental delay (DD) is increasing with next-generation sequencing technologies identifying genetic variants in patients with these disorders. However, detailed analyses conclusively confirming variants, as well as the underlying molecular mechanisms...
Published: 6/25/2019   |   Inventor(s): Erin Ahn, Jung-Hyun Kim, Ssang-Taek Lim
Keywords(s):  
Category(s): Biomarkers, Screening Tests, All Technologies
SON Isoform Ratio for Acute Myeloid Leukemia Diagnosis
OPPORTUNITY Acute myeloid leukemia is a cancer of the blood, bone marrow and other tissues. Although treatment for acute myeloid leukemia has improved, it is only curable in 35-40% of people 60 years old or younger and in 5-15% of patients over the age of 60. Median survival of patients that do not receive intensive chemotherapy is only 5-10 months....
Published: 6/12/2024   |   Inventor(s): Erin Ahn, Jung-Hyun Kim, Ssang-Taek Lim
Keywords(s):  
Category(s): Biomarkers, Screening Tests, All Technologies
Micro-RNA Makers for Colon Cancer
Invention Referene: 10/MED/349 This technology relates to methods of detecting the presence of specific RNA sequences in a biological sample for diagnosing or providing a prognosis for colon cancer (CRC). 　 　 AdvantagesEarly detection and removal of adenoma has been shown to reduce the incidence and mortality of CRC. Colonoscopy...
Published: 12/14/2020   |   Inventor(s): Jun Yu, Jao Yiu Joseph Sung, Chung Wah Wu
Keywords(s):  
Category(s): Diagnostics
Epigenetic Biomarker for Diagnosis and Prognosis of Gastric Cancer
 
Published: 8/25/2020   |   Inventor(s): Jun Yu, Jao Yiu Joseph Sung
Keywords(s):  
Category(s): Diagnostics